Skip to main content

Table 2 Summarization of the ocular disease models using ROs

From: Retinal organoids as models for development and diseases

Disease

Genes

Mutations

Year

Notes

References

RP

RPGR

c.1685_1686delAT

2018

Gene correct

(Deng et al. 2018)

c.2234_2235delGA

c.2403_2404delAG

RP

USH2A

c.8559-2A > G

2019

 

(Guo et al. 2019)

c.9127_9129delTCC

RP

RP2

RP2 NULL

2020

AAV gene augmentation

(Lane et al. 2020)

RP2 R120X

RP

CRB1

Y631C; G850S

2020

 

(Zhang et al. 2020b)

RP

NRL

NRL NULL

2020

 

(Kallman et al. 2020)

RP

PRPF31

c.1115_1125del11

2018

Gene correct

(Buskin et al. 2018)

c.522_527 + 10del

RP

CRB1

Homozygous M1041T

2019

 

(Quinn et al. 2019)

E995X;Y631C

C948Y;M1041T

RP

TRNT1

Glu43del3 GAA;p.Ser418del1Afs

2017

 

(Sharma et al. 2017)

Ser418Ins1Afs; c.609-26 T > C

RP

PDE6B

E232K

2020

 

(Gao et al. 2020)

RP

CLN3

A59T

2021

Gene correct

(Zhang et al. 2021)

RP

NR2E3

G56R

2021

 

(Diakatou et al. 2021)

RP

RP17

Structural variants

2020

 

(de Bruijn et al. 2020)

LCA

RPE65

L67R; Y144H

2019

 

(Li et al. 2019)

LCA

CEP290

Homozygous IVS26 + 1655A > G

2017

 

(Shimada et al. 2017)

LCA

AIPL1

C89R

2020

 

(Lukovic et al. 2020)

LCA

CRX

I138fs48; K88N

2021

AAV-mediated augmentation

(Kruczek et al. 2021)

Glaucoma

OPTN

E50K

2020

 

(VanderWall et al. 2020)

Macular telangiectasia type 2

SPTLC1

C133Y

2019

 

(Gantner et al. 2019)

Microphthalmia

VSX2

Homozygous R200Q

2020

 

(Eintracht et al. 2020)

Retinoblastoma

MYCNOS

MYCNOS NULL

2020

 

(Saengwimol et al. 2020)

Retinoblastoma

RB1

RB1 NULL

2020

 

(Liu et al. 2020)

Homozygous R320X

Retinoblastoma

RB1

RB1 NULL

2020

 

(Deng et al. 2020)

Stargardt Disease

ABCA4

c.5196 + 1137G > A

2020

Antisense oligonucleotides therapy

(Khan et al. 2020)

X-linked juvenile retinoschisis

RS1

C625T

2019

Base editing

(Huang et al. 2019)